Search
for
Sort by
Research 451–480 of 1000+
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
- Autistic-undisciplined thinking in the practice of medical trichology
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- MANAGING ESTROGEN-DEFICIENT SKIN: A NARRATIVE REVIEW ON THE ROLE OF HRT AND EMERGING ESTROGEN-MODULATING THERAPIES
- Female pattern hair loss: therapeutic update
- Comorbid laboratory abnormalities in female pattern hair loss patients
- Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism
- Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review includingGRADEassessments
- Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol
- THE TREATMENT OF HIRSUTISM WITH A COMBINATION OF DESOGESTREL AND ETHINYL OESTRADIOL
- The Evaluation of the Role of Androgens in Hirsutism and the Use of a New Anti-androgen “Cyproterone Acetate” for Therapy
- Contraception for the 21st Century
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- Comparison of two contraceptive pills containing drospirenone and 20 μg or 30 μg ethinyl estradiol for polycystic ovary syndrome
- Use of oral contraceptives in the management of acne
- Miscellaneous Exogenous Hormones and Breast Diseases: A Matter of Concern for the Gynecologist
- Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with polycystic ovary syndrome.
- Effect of contraceptives on the skin.
- Treatment of hirsutism and acne in hyperandrogenism
- Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne
- A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
- DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- GhDET2, a steroid 5α‐reductase, plays an important role in cotton fiber cell initiation and elongation
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
- A New Look at the 5?-Reductase Inhibitor Finasteride
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production